Guangyong Zheng
Overview
Explore the profile of Guangyong Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Zhang L, Zhang W, Chen H, Hong M, Xia J, et al.
Chin Med
. 2025 Feb;
20(1):23.
PMID: 39953557
Breast cancer (BC) is a prevalent form of cancer among women. Despite the emergence of numerous therapies over the past few decades, few have achieved the ideal therapeutic effect due...
2.
Chen H, Lu D, Xiao Z, Li S, Zhang W, Luan X, et al.
Health Inf Sci Syst
. 2024 Aug;
12(1):41.
PMID: 39130617
Purpose: Target-based strategy is a prevalent means of drug research and development (R&D), since targets provide effector molecules of drug action and offer the foundation of pharmacological investigation. Recently, the...
3.
Zhou H, Shen Y, Zheng G, Zhang B, Wang A, Zhang J, et al.
Clin Transl Med
. 2024 May;
14(5):e1701.
PMID: 38778448
Background: Mucinous colorectal adenocarcinoma (MCA) is a distinct subtype of colorectal cancer (CRC) with the most aggressive pattern, but effective treatment of MCA remains a challenge due to its vague...
4.
Ma C, Zhao J, Zheng G, Wu S, Wu R, Yu D, et al.
Phytomedicine
. 2024 Mar;
128:155424.
PMID: 38537441
Background: Leukopenia could be induced by chemotherapy, which leads to bone marrow suppression and even affects the therapeutic progression of cancer. Qijiao Shengbai Capsule (QSC) has been used for the...
5.
Wang Q, Wang J, Yu D, Zhang Q, Hu H, Xu M, et al.
Cell Rep Med
. 2024 Jan;
5(2):101357.
PMID: 38237597
Programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) blockade has become a mainstay of cancer immunotherapy. Targeting the PD-1/PD-L1 axis with small molecules is an attractive approach to enhance antitumor...
6.
Feng J, Liu H, Mai S, Su J, Sun J, Zhou J, et al.
BMC Public Health
. 2023 Sep;
23(1):1700.
PMID: 37660022
Background: Nutrition service needs are huge in China. Previous studies indicated that personalized nutrition (PN) interventions were effective. The aim of the present study is to identify the effectiveness and...
7.
Li S, Lu C, Zhao Z, Lu D, Zheng G
Front Aging Neurosci
. 2023 Jun;
15:1161405.
PMID: 37333458
Background: Neuroinflammation is one of the key factors leading to neuron death and synapse dysfunction in Alzheimer's disease (AD). Amyloid-β (Aβ) is thought to have an association with microglia activation...
8.
Zhu Z, Wang Z, Zang J, Lu Y, Xiao Z, Zheng G, et al.
Nutrients
. 2022 May;
14(10).
PMID: 35631165
This study aimed to explore the role of the single nucleotide polymorphism (SNP) rs516946 of the Ankyrin 1 (ANK1) gene in the relationship between dietary iron and metabolic syndrome (MetS)...
9.
Zou H, Zhang M, Zhu X, Zhu L, Chen S, Luo M, et al.
Front Microbiol
. 2022 May;
13:826487.
PMID: 35516426
Gut microbiota plays an important role in metabolic homeostasis. Previous studies demonstrated that ginsenoside Rb1 might improve obesity-induced metabolic disorders through regulating glucose and lipid metabolism in the liver and...
10.
Ma L, Liao Y, Fan H, Zheng X, Zhao J, Xiao Z, et al.
Front Genet
. 2022 May;
13:877870.
PMID: 35495148
Currently, most of the personal health data (PHD) are managed and stored separately by individual medical institutions. When these data need to be shared, they must be transferred to a...